Login
$SGP
$31.67 -$1.21 (3.68%) Live

Company Executives

Management Team

From the 10-K annual report
Officer Age In this role Source
Patrick Mooney Also a director
Chief Executive Officer and Director
52 Since 2021
5 years
Jean-Frédéric Viret, Ph.D.
Chief Financial Officer
60 Since 2026
this year
Malik Y. Kahook, M.D. Also a director
Co-founder, President, Chief Medical Officer, Executive Chair of the Board and Director
51 Not stated
James Dennewill
Chief Operating Officer
45 Since 2021
5 years
Chetan Pujara, Ph.D.
Chief Research and Development Officer
56 Since 2025
1 year

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 10-K annual report

Directors
10
serving now
Independent
0 of 2
stated in the proxy; 8 not stated
Average tenure
3.2 years
from year joined
CEO also chairs the board
No
Malik Y. Kahook, M.D.
Director Age On board Independent Committees Other public boards Pay Source
Malik Y. Kahook, M.D.
51 2019
7 years
Not independent None stated None stated Not stated
Patrick Mooney
52 2021
5 years
Not independent None stated None stated Paid as CEO
Ali Behbahani, M.D.
49 2019
7 years
Not stated
compensation committee
Adaptimmune Therapeutics Plc, Black Diamond Therapeutics, CRISPR Therapeutics AG, Monte Rosa Therapeutics, Inc., Nkarta, Inc., Korro Bio, Inc., Arcellx, Inc. Not stated
Habib J. Dable
56 Not stated Not stated
compensation committee
Relay Therapeutics, Day One Biopharmaceuticals, PepGen Not stated
Michael Dybbs, Ph.D.
51 2025
1 year
Not stated
audit committee
Nkarta, Inc., Sutro Biopharma, Inc., Kalaris Therapeutics, Inc. Not stated
Bilal Khan
45 2023
3 years
Not stated
compensation committee nominating and corporate governance committee
None stated Not stated
Kirk Nielsen
52 2025
1 year
Not stated
audit committee
CVRx Not stated
Elizabeth O’Farrell
61 2025
1 year
Not stated
audit committee
Genmab A/S, PDL BioPharma, Geron Corporation, LENSAR Not stated
Geoff Pardo
54 2025
1 year
Not stated
nominating and corporate governance committee
Mainstay Medical Holding plc, Nalu Medical, Alleviant Medical, Shoulder Innovations, Ablative Solutions Not stated
Zach Scheiner, Ph.D.
49 2023
3 years
Not stated
nominating and corporate governance committee
Nkarta Therapeutics, Inc., LENZ Therapeutics, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. SpyGlass Pharma, Inc. has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support